Exact Sciences Announces First Quarter 2021 Results

Go back to Exact Sciences Announces First Quarter 2021 Results

Exact Sciences (EXAS) Posts Smaller Q1 Loss

May 4, 2021 4:02 PM EDT

Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.18), $0.85 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $402.1 million versus the consensus estimate of $388.57 million.

"The first quarter demonstrated Exact Sciences is well-positioned for growth today and into the... More